JW Therapeutics Acquires Syracuse Biopharma and License to Eureka Therapeutics’ Solid Tumor Technology in China Read more
Exclusive Interview with Matts Ramstorp ahead of SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom Read more
Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab Read more
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19 Read more
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK Read more
BioAegis Therapeutics Receives Approval to Proceed with Phase 2 Trial of its Gelsolin COVID-19 Treatment Read more